6.66 USD
+0.15 (+2.3%)
ChartMill assigns a Buy % Consensus number of 83% to CNSP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.04. This target is 696.4% above the current price.
CNSP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CNSP.
In the previous month the buy percentage consensus was at a similar level.
CNSP was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-12 | Maxim Group | Upgrade | Hold -> Buy |
| 2025-03-25 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-09-10 | Maxim Group | Upgrade | Hold -> Buy |
CNS PHARMACEUTICALS INC / CNSP FAQ
Can you provide the average price target for CNS PHARMACEUTICALS INC stock?
8 analysts have analysed CNSP and the average price target is 53.04 USD. This implies a price increase of 696.4% is expected in the next year compared to the current price of 6.66.
What is the consensus rating for CNS PHARMACEUTICALS INC (CNSP) stock?
The consensus rating for CNS PHARMACEUTICALS INC (CNSP) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CNSP stock?
The number of analysts covering CNS PHARMACEUTICALS INC (CNSP) is 8.